Boiron Sa Stock Fundamentals

BOI Stock  EUR 28.10  1.40  4.75%   
Boiron SA fundamentals help investors to digest information that contributes to Boiron SA's financial success or failures. It also enables traders to predict the movement of Boiron Stock. The fundamental analysis module provides a way to measure Boiron SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Boiron SA stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Boiron SA Company Operating Margin Analysis

Boiron SA's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Boiron SA Operating Margin

    
  0.15 %  
Most of Boiron SA's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Boiron SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, Boiron SA has an Operating Margin of 0.147%. This is 100.42% lower than that of the Healthcare sector and 99.27% lower than that of the Drug Manufacturers - Major industry. The operating margin for all France stocks is 102.67% lower than that of the firm.

Boiron SA Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Boiron SA's current stock value. Our valuation model uses many indicators to compare Boiron SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Boiron SA competition to find correlations between indicators driving Boiron SA's intrinsic value. More Info.
Boiron SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.65  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Boiron SA is roughly  1.55 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Boiron SA by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Boiron SA's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Boiron Operating Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Boiron SA's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Boiron SA could also be used in its relative valuation, which is a method of valuing Boiron SA by comparing valuation metrics of similar companies.
Boiron SA is currently under evaluation in operating margin category among its peers.

Boiron Fundamentals

About Boiron SA Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Boiron SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Boiron SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Boiron SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. Boiron SA was founded in 1932 and is headquartered in Messimy, France. BOIRON operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 3084 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Boiron Stock

Boiron SA financial ratios help investors to determine whether Boiron Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Boiron with respect to the benefits of owning Boiron SA security.